• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Press Release: Nemera wins the “Editor’s choice” Exhibitor Award at Interphex with its autoinjector Safelia

March 22, 2017 By Sarah Faulkner

Press Release: Nemera wins the "Editor's choice" Exhibitor Award at Interphex with its autoinjector Safelia(Press release) – International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral Drug Association (PDA), has announced the winners for the INTERPHEX Exhibitor Awards for 2017.

Nemera was recognized for the ‘Editor’s choice’ for Safelia.

Safelia is an innovative autoinjector for prefilled syringes, available for 1 and 2.25 m sizes, suitable for large volume and high viscosity delivery through thinner needles. Safelia can mechanically “tune” the injection thanks to design adjustments. It has been designed to ease patients’ self-injection experience and to deliver the most challenging drugs, in subcutaneous or intramuscular layers.

“There is no limit to Nemera’s ambition to serve patients. We already market devices in over 40 countries for millions of users. We’ll keep investing in new products and in state-of-the-art manufacturing equipment, to help even more patients with high quality devices all over the world,” Marc Hamel, CEO, said.

Key benefits of Safelia:

Patient friendly
• No initial injection peak
• Constant delivery flow
• Adjustable needle insertion speed
• Needle insertion disconnected from injection
• Automatic needle retraction
• Possibility to have thinner needles

Syringe friendly
• Syringe is held encapsulated through the barrel
• Syringe front housing
• No stress on the syringe flange
• Possibility to inject very viscous drugs

Safelia will also be shown at next events we will attend:
• SMI PFS East Coast, April 26-27, Boston, MA, US
• FCE Pharma, May 23-25, Sao Paulo, Brazil
• SMI PFS West Coast, June 6-7, San Diego, CA, US
• CPhI China, June 20-22, Shanghai, China
• CPhI WorldWide, October 24-26, Frankfurt, Germany
• PDA Prefilled syringes and Injection devices, November 7-8, Vienna, Austria
• CPhI India, November 28-30, Bombay, India

To win an INTERPHEX Exhibitor Award, the exhibit/booth must excel in each criterion, rise above competitors, and clearly reflect excellence in pharma and biopharma development and manufacturing.

The judges evaluated each submitting exhibitors booth based on the following criteria:
• Overall Appeal/Experience (Design)
• Knowledge (Content)
• Product/Service Innovation
• New Technologies or Novel Implementation of Existing Technologies
• Advances in Features and Performance
• Development of Novel Technologies
• Novel Implementation of Existing Technologies
• Advances in Services Provision
• Significant New Services Additions
• Showcasing of Technical Knowledge

The judges on this year’s Exhibitor Awards panel were:
• Meg Snyder, Editor at Pharmaceutical Processing
• David Hall, Vice President of Sales at Parenteral Drug Association (PDA)
• Barry Holtz, Principal at Holtz Biopharma Consulting
• Eric Jayjock, PhD, Director of Continuous Manufacturing at Patheon
• Christa Myers, Associate, Lead Process Engineer at CRB
• Gil Roth, Founder and President of the Pharma & Biopharma Outsourcing Association
• Matthew VonEsch, Senior Director Manufacturing at Exelead

Materials in this report were provided by Nemera. 

Filed Under: Auto-injectors, Drug-Device Combinations, Featured Tagged With: Nemera

IN CASE YOU MISSED IT

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Glucotrack can proceed with long-term glucose monitor study in Australia
  • Dexcom promotes Jake Leach to president role
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS